Hirasawa T - Search Results

1

Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma.

Tsukada H, Muramatsu T, Miyazawa M, Iida T, Ikeda M, Shida M, Hirasawa T, Kajiwara H, Murakami M, Yasuda M, Mikami M. Tsukada H, et al. Among authors: hirasawa t. Acta Histochem Cytochem. 2012 Apr 26;45(2):147-54. doi: 10.1267/ahc.11063. Epub 2012 Apr 21. Acta Histochem Cytochem. 2012. PMID: 22685357 Free PMC article.

2

[Intermediate filaments].

Hirasawa T, Yasuda M, Osamura Y. Hirasawa T, et al. Nihon Rinsho. 1996 Jun;54(6):1542-50. Nihon Rinsho. 1996. PMID: 8691607 Review. Japanese.

3

Excessive formation of basement membrane substance in clear-cell carcinoma of the ovary: diagnostic value of the "raspberry body" in ascites cytology.

Ito H, Hirasawa T, Yasuda M, Osamura RY, Tsutsumi Y. Ito H, et al. Among authors: hirasawa t. Diagn Cytopathol. 1997 Jun;16(6):500-4. doi: 10.1002/(sici)1097-0339(199706)16:6<500::aid-dc6>3.0.co;2-d. Diagn Cytopathol. 1997. PMID: 9181315

4

Cytologic study of ascites and the endometrium in ovarian carcinoma. Clinical significance.

Hirasawa T, Yasuda M, Muramatsu T, Itoh H, Shinozuka T, Makino T, Tsutsumi Y, Osamura RY. Hirasawa T, et al. Acta Cytol. 1997 Sep-Oct;41(5):1451-5. doi: 10.1159/000332858. Acta Cytol. 1997. PMID: 9305383

5

Serous borderline ovarian tumor with functioning stroma in a postmenopausal woman: immunohistochemical analysis of steroidogenic pathway.

Yasuda M, Itoh J, Hirasawa T, Hirazono K, Shinozuka T, Sasano H, Osamura RY. Yasuda M, et al. Among authors: hirasawa t. Int J Gynecol Pathol. 1998 Jan;17(1):75-8. doi: 10.1097/00004347-199801000-00013. Int J Gynecol Pathol. 1998. PMID: 9475196

6

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma: long term results for 105 patients.

Shinozuka T, Miyamoto T, Muramatsu T, Hirasawa T, Murakami M, Makino T, Tanaka Y. Shinozuka T, et al. Among authors: hirasawa t. Cancer. 1999 Apr 1;85(7):1555-64. doi: 10.1002/(sici)1097-0142(19990401)85:7<1555::aid-cncr17>3.0.co;2-4. Cancer. 1999. PMID: 10193946 Clinical Trial.

7

Myxoid leiomyoma of the vulva: a case report.

Kajiwara H, Yasuda M, Yahata G, Yamauchi I, Satoh S, Hirasawa T, Osamura RY. Kajiwara H, et al. Among authors: hirasawa t. Tokai J Exp Clin Med. 2002 Sep;27(3):57-64. Tokai J Exp Clin Med. 2002. PMID: 12701642 Review.

8

Effect of peripheral blood progenitor cell dose on hematopoietic recovery: identification of minimal progenitor cell requirements for rapid engraftment.

Miyamoto T, Shinozuka T, Maeda H, Hirasawa T, Muramatsu T, Murakami M, Makino T, Itagaki H, Nakamura Y. Miyamoto T, et al. Among authors: hirasawa t. Bone Marrow Transplant. 2004 Mar;33(6):589-95. doi: 10.1038/sj.bmt.1704412. Bone Marrow Transplant. 2004. PMID: 14743198

9

Uterine body cancer mass screening at Tokai University Hospital.

Nagase E, Yasuda M, Kajiwara H, Osamura RY, Yoshitake T, Hirasawa T, Muramatsu T, Miyamoto T, Murakami M, Makino T, Ogawa T. Nagase E, et al. Among authors: hirasawa t. Tokai J Exp Clin Med. 2004 Jun;29(2):43-8. Tokai J Exp Clin Med. 2004. PMID: 15473339

10

Clinical usefulness of serum and immunohistochemical markers in patients with stage Ia and Ic ovarian cancer.

Muramatsu T, Mukai M, Sato S, Tajima T, Nagase E, Ikeda M, Goya K, Shida M, Hirasawa T, Murakami M, Shinozuka T. Muramatsu T, et al. Among authors: hirasawa t. Oncol Rep. 2005 Oct;14(4):861-5. Oncol Rep. 2005. PMID: 16142343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

573 results

Search Page

Filters